| abstract |
The use of at least one compound of formula (I) in the manufacture of a medicament for treating drug-resistant HIV in a subject wherein n is 0 to 6; R is H, halogen (C1-C12) alkyl, (C1-C12) alkoxy, amino, cyano, nitro, or hydroxy; and R1 comprises cyclo (C3-C12) alkyl, cyclo (C3-C12) alkenyl, isothiazolyl, tetrazolyl, triazolyl, pyridyl, imidazolyl, phenyl, napthyl, benzoxazolyl, benzimidazolyl, thiazolyl, oxazolyl, benzothiazolyl, pyrazinyl, pyridazinyl, thiadiazolyl, benzotriazolyl, pyrolyl, indolyl, benzothienyl, thienyl, benzofuryl, quinolyl, isoquinolyl, or pyrazolyl; or a pharmaceutically acceptable addition salt thereof. |